According to Memorial Sloan Kettering Cancer Center, rare cancer patients make up around half of all people fighting cancer.
NEW YORK, March 26, 2018 (Newswire.com) - Cancer patients often have limited or no treatment options available to them due to drastic underfunding into rare cancer research.
"This is why we ride," state Memorial Sloan Kettering.
Research into rare cancers is drastically underfunded.
Natalia Sishodia
The center's Cycle for Survival event raised $34 million last year, adding to a total of over $179 million in the last decade.
Cycle for Survival relies on donations and sponsorship to raise the vital funds needed in supporting the movement to beat rare cancers.
"Research into rare cancers is drastically underfunded," says Natalia Sishodia, a New York Real Estate Broker at Brown Harris Stevens supporting friends who are partaking in the 2018 Cycle for Survival event.
"These cancers include brain, ovarian, thyroid, pancreatic, and stomach cancers, as well as leukemia, lymphoma, and pediatric cancers," adds Sishodia.
She continues, "I'm proud to pledge my support for Cycle for Survival, and my friends taking part, knowing that 100% of funds raised go directly towards cancer research at Memorial Sloan Kettering."
Memorial Sloan Kettering is the world's largest and oldest private cancer center. Over 100 additional research studies, initiatives, and clinical trials have been funded at the center over the last ten years thanks to Cycle for Survival.
"Cycle for Survival funding has driven advances in cancer care, such as sequencing tumor DNA, developing individualized treatments, and launching groundbreaking clinical trials, among other innovative studies," says the cancer hospital and research center of the funds raised and the work subsequently supported.
"On average, each team of four partaking in Cycle for Survival raises over $5,000," notes Sishodia. "That's why every single person taking part is so important."
Memorial Sloan Kettering further adds, "The work supported by Cycle for Survival has led to important discoveries. Many doctors and scientists on the front lines in the battle against rare cancers couldn't have pursued innovative ideas without Cycle for Survival funding."
Of the funding, Ira J. Dunkel, a doctor from Memorial Sloan Kettering's Department of Pediatrics remarks, "Children with brain cancers urgently need better and safer treatment options and more effective ways to deliver therapy. Cycle for Survival funding has been critical in advancing the research and clinical trials that will help pediatric patients."
"One way or another, cancer affects all of us during our lifetimes," points out Natalia Sishodia. "It's a terrible disease, and it's time we put an end to it."
"That's why," she concludes, "we should all be involved in the fight to beat cancer together, through initiatives such as Cycle for Survival."
Cycle for Survival takes place throughout January, February, and March, in locations around New York and across the U.S. To find out more, or to donate, visit https://www.cycleforsurvival.org.
Media Contact:
Eric Blankenship
Eric@netreputation.com
786-332-6554
Source: Web Presence, LLC
Share: